Basic Information
Carrington Laboratories, Inc. is developing and commercializing GelSite polymer as a controlled-release drug delivery technology for protein/peptide therapeutics and vaccine products. This synthetic typhoid vaccine represents a unique and significant application of the gel-like polymer.
Carrington Laboratories,Inc.
Texas,United States of America
101~500 people
January 01, 1973
--
--

